Oncosoft executive outlines company market positioning
Han Joo Chae, Chief Business and Technology Officer at Oncosoft, discussed the firm’s strategic market approach and its current role within the oncology software sector in an interview with CB Insights.
Oncosoft is currently positioning its technology within the oncology software market, focusing on specific user requirements and clinical workflows. The company, led by Chief Business and Technology Officer Han Joo Chae, is navigating an increasingly crowded digital health landscape where data integration remains a primary hurdle.
During the discussion, Chae emphasized that the company’s internal roadmap is driven by shifting customer needs within healthcare providers. By focusing on software infrastructure, Oncosoft aims to address the technical complexities clinicians face when managing oncological patient data.
The insights provided by Chae highlight the broader trend of digital transformation in oncology, where specialized software is increasingly required to bridge the gap between diagnostic results and patient management. The company continues to prioritize scaling its footprint as clinical adoption of specialized oncology tools rises.